Image Credit:
Lithuanian laser technologies go beyond scientific research, as they are also used in industry, medicine, telecommunications and many other fields. They even have a worldwide impact, as 95 out of 100 leading universities in the world use Lithuanian lasers, and organisations such as NASA and CERN also rely on them. More than 89 per cent of laser technologies created in Lithuania are exported, and the sector reached an average growth of 20 per cent annually in 2021-2023. The achievements of the Lithuanian laser sector are perfectly illustrated by the prestigious SPIE Prism award for the best laser FemtoLux30, awarded this year to one of the industry leaders – the company, Ekspla.
Image Credit:
Towards an advanced tomorrow – on the growth wave of start-ups
The vitality and growth of these innovation sectors is supported by the vibrant ecosystem of Lithuanian start-ups. It consists of over 1,000 innovative start-ups, employing more than 18,000 talents. This ecosystem has already produced three unicorns.
Image Credit:
The total value of Lithuanian start-ups increased more than 7 times from 2018 to 2023 and reached 13.7 billion euros. This growth was much faster than in the region – during the same period, the value of start-ups in the Central and Eastern Europe region increased by 3.6 times, and by 2.7 times in the Baltic countries.
Promising Lithuanian start-ups also attract more and more investments. In 2023, Lithuania was second in the entire region of Central and Eastern Europe, both in terms of the total attracted early-stage investments and in terms of their share per inhabitant of the country. Lithuanian start-ups are most active in the fields of software, business, financial technologies and life sciences and health technologies, and they have launched more than one successful product on the market.
Image Credit:
Caszyme explores opportunities in UAE
Caszyme is one of the brightest stars of the Lithuanian start-up ecosystem and life sciences. Specialising in the development of CRISPR-Cas gene editing technology, the company is developing new and efficient gene editing tools that help scientists around the world apply this technology in their activities and create commercial products based on it.
Caszyme aims to expand the possibilities of CRISPR-Cas technology in various fields of application of this method, from medical research and therapy to agriculture and the food industry.
One of the founders of the company is Virginijus Šikšnys, professor and biochemist, who contributed to the discovery of the CRISPR-Cas9 method. Caszyme currently has a total of 25 employees, most of whom are researchers in the field of life sciences.
The solutions they develop can help diagnose and treat various diseases more effectively, increase the resistance of food crops to climate change, and also have beneficial applications in other areas. While the company mainly works with the US, Southeast Asia and European markets, it is also looking for new cooperation opportunities in other regions, including the UAE.
Cooperation with researchers and companies from these countries can open new opportunities for one of the leading biotechnology companies in the region, thereby stimulating further development in the science of genetics.
Source link : http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=670fa0d33bf549898b25786846ebba08&url=https%3A%2F%2Fgulfnews.com%2Fgn-focus%2Ffrom-biotechnologies-to-lasers-how-lithuania-became-a-regional-innovation-centre-1.1729073132899&c=15134510997129551282&mkt=en-us
Author :
Publish date : 2024-10-16 03:05:00
Copyright for syndicated content belongs to the linked Source.
